Iris Colors in Neonates: Do They Really Change? Prevalence, Predicting Factors and Associated Characteristics

March 1, 2017 updated by: Hillel Yaffe Medical Center
The goal of our study is to examine eye color at birth and the longitudinal change in eye color of preterm and full-term newborns.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hadera, Israel, 38100
        • Hillel Yaffe Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 days to 2 months (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Any baby born between the 24-42 week of gestation admitted to the well-baby nursery or the NICU whose parents have signed an informed consent.

Exclusion Criteria:

  • Neonatal conjunctivitis
  • Neonatal sepsis
  • Inborn error of metabolism or genetic syndrome
  • Eye abnormalities
  • Parental refusal

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Blue eyes
50 babies born with blue eyes will be photographed and followed-up at baseline; 3 months and 12 months of age
Babies will be photographed and eye color will be observed and documented at birth, 3 months and one year of age
Active Comparator: Brown eyes
50 babies born with brown eyes will be photographed and followed-up at baseline; 3 months and 12 months of age
Babies will be photographed and eye color will be observed and documented at birth, 3 months and one year of age
Active Comparator: Green eyes
50 babies born with green eyes will be photographed and followed-up at baseline; 3 months and 12 months of age
Babies will be photographed and eye color will be observed and documented at birth, 3 months and one year of age
Active Comparator: Hazel eyes
50 babies born with hazel eyes will be photographed and followed-up at baseline; 3 months and 12 months of age
Babies will be photographed and eye color will be observed and documented at birth, 3 months and one year of age

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in eye color
Time Frame: One year
Change will be measured according to a validated classification of blue/hazel/green or brown
One year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Amit Hochberg, MD, Hillel Yaffe Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

March 1, 2017

Primary Completion (Anticipated)

April 1, 2018

Study Completion (Anticipated)

April 1, 2018

Study Registration Dates

First Submitted

February 27, 2017

First Submitted That Met QC Criteria

March 1, 2017

First Posted (Actual)

March 7, 2017

Study Record Updates

Last Update Posted (Actual)

March 7, 2017

Last Update Submitted That Met QC Criteria

March 1, 2017

Last Verified

February 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • HYMC-0081-16

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Eye Color

Clinical Trials on Photograph

Subscribe